AKER News and Press, Akers Biosciences Inc. From 09/08/20

Are These Good Penny Stocks To Buy Right Now? If you’re looking for good penny stocks to buy right now, what are you looking for? I’m sure momentum is one thing and maybe, news is another. But what about chart patterns? Is technical analysis part of your strategy? Many trade...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify . Stocks wrapped up another strong week on a high note, as the Federal Reserve’s new, more tolerant approach to inflation rippled t...

Gainers:  VBI Vaccines (NASDAQ: VBIV ) +35% . More news on: VBI Vaccines Inc., Rekor Systems, Inc., BMC Stock Holdings, Inc., Stocks on the move, , Read more ...

Nano cap Akers Biosciences ( AKER -28.1% ) slumps on more than a 5x surge in volume in reaction to proof-of-concept data from animal studies assessing the safety and immunogenicity of its SARS-CoV-2 vaccine candidate, dubbed PRAK3202, that it is co-developing with Premas Biotech. More ...

Thorofare, New Jersey, Aug. 27, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced with its partner, Premas Biotech, positive proof of concept results from Animal Studies conduc...

Gainers:  Hancock Jaffe Laboratories (NASDAQ: HJLI ) +127% . More news on: Hancock Jaffe Laboratories, Inc., Harpoon Therapeutics, Inc., ShiftPixy, Inc., Stocks on the move, , Read more ...

Fennec Pharmaceuticals (NASDAQ: FENC )   -31%  on FDA rejection of Pedmark application. More news on: Fennec Pharmaceuticals Inc., Mesoblast Limited, Genesis Healthcare, Inc., Stocks on the move, , Read more ...

Thorofare, New Jersey, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), today announced that it has entered into definitive agreements with several institutional and accredited investors for the purchase and sale of 1,207,744 shares of ...

Company intends to cease focus on screening and testing products business Thorofare, New Jersey, July 07, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced with its partner,...

Thorofare, New Jersey, May 18, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced the closing of its previously announced registered direct offering of an aggregate of 1,366,856...